1401079-59-1Relevant academic research and scientific papers
Properly substituted cyclic bis-(2-bromobenzylidene) compounds behaved as dual p300/CARM1 inhibitors and induced apoptosis in cancer cells
Altucci, Lucia,Benedetti, Rosaria,Conte, Mariarosaria,Di Bello, Elisabetta,Fioravanti, Rossella,Mai, Antonello,Novellino, Ettore,Plateroti, Andrea Maria,Romanelli, Annalisa,Tomassi, Stefano,Valente, Sergio
, (2020)
Bis-(3-bromo-4-hydroxy)benzylidene cyclic compounds have been reported by us as epigenetic multiple ligands, but different substitutions at the two wings provided analogues with selective inhibition. Since the 1-benzyl-3,5-bis((E)-3-bromobenzylidene)piper
